ChromaDex(R) Corporation announced that it has signed a distribution agreement with IsoLife bv. These (13) C- and (15) N-labeled phytochemicals and plant products are used as tracers and internal standards for food & beverage, nutraceutical, pharmaceutical, cosmeceutical and environmental sciences research. The IsoLife agreement will add to ChromaDex's comprehensive and growing catalog, which contains more than 3,000 phytochemicals and 500 botanical reference materials.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | -5.21% | +10.65% | +103.50% |
07-16 | ChromaDex Corp. Announces Pharmaceutical-Grade Intravenous and Injectable Niagen®? Will Debut At Leading Wellness Clinics in August | CI |
07-01 | ChromaDex Joins Russell 2000 Index | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.50% | 220M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+46.17% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- ChromaDex Corporation Signs Distribution Agreement with IsoLife bv